GT: The Podcast cover art

All Episodes

GT: The Podcast — 87 episodes

#
Title
1

Survey Says: Intervention for Controlled Glaucoma

2

Surgical Management of UGH Syndrome

3

Reflections on Change

4

The Paul Glaucoma Implant

5

Glaucoma Intrascleral Tube Surgery

6

Tube Erosion

7

Survey Says: Reducing Medication Burden for an Unhappy Patient

8

The Role of Anterior Segment OCT in MIGS

9

Sustained Drug Delivery in Interventional Glaucoma

10

A Cilioscleral Interpositioning Device

11

Survey Says: Choosing Treatment for a High-Risk Patient

12

Career Change: Making the Vision Come to Life • Private Practice Versus Academia

13

Metabolic Dysfunction in Glaucoma

14

Survey Says: Proceeding After Unsuccessful Treatment

15

Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation

16

Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye

17

Survey Says: Treatment for a High-Risk Patient

18

Chronic Stress and Glaucomatous Progression • Advances in Eye Drop Aids

19

Improving the Affordability of Glaucoma Medications

20

Initial Visits and Long-term Care of Glaucoma Patients in Primary Eye Care Settings

21

Survey Says: Next Steps for Slowly Progressive Disease

22

Masqueraders of Normal-Tension Glaucoma

23

DARC: From Bench to Bedside

24

Is Glaucoma Policy Short-Sighted?

25

Back to Basics: Patient Encounters in Glaucoma

26

Clinical Experiences With the Hydrus Microstent

27

Survey Says: Fluctuating IOP and Poor Compliance

28

Establishing a Glaucoma Practice Fresh Out of Fellowship

29

Learning and Teaching MIGS

30

Survey Says: Which Treatment Next?

31

Clinical Experiences With the Hydrus Microstent

32

Management of Tube Erosion

33

Geographic Atrophy: A New Treatment Paradigm

34

Patient Experience Data Collection

35

Prioritizing Processes Over Goals

36

Survey Says: Target IOP and Next Steps

37

Suprachoroidal Hemorrhage

38

Waste in Ophthalmology ORs

39

Patients on Reddit

40

Noninvasive Trabeculotomy Treatment for Glaucoma

41

Remote Monitoring of Glaucoma

42

Retinal Nerve Fiber Layer Optical Texture Analysis

43

Teleophthalmology for Incidental Glaucoma Screening

44

Survey Says: Procedure and IOL Selection

45

Leading Through Uncertainty

46

Physician Burnout in Ophthalmology

47

Survey Says: Determining Target IOP and Next Steps

48

Glaucoma Visionaries: Sean Ianchulev, MD, MPH

49

Glaucoma Visionaries: Joel S. Schuman, MD, FACS

50

‘Survey Says’ With I. Paul Singh, MD

51

Glaucoma Visionaries: Malik Y. Kahook, MD

52

Remote Diagnostics for Closer Clinical Teamwork

53

Introducing 'Survey Says' With I. Paul Singh, MD

54

Lessons In Dissatisfaction • Not Your Grandma’s Puff Test

55

A Holistic Approach to Glaucoma Care

56

Reducing Pigment Particles in the Anterior Chamber

57

Dose & Delivery: Defining Target IOP Ranges

58

Is It Time to Rethink the Slit Lamp?

59

The Contrast Sensitivity Story

60

Dose & Delivery: New Mechanisms of Action

61

The New Attending’s Perspective on MIGS

62

Complications With Xen Implantation and how to Avoid Them

63

Tips and Tricks for the XEN Gel Stent

64

Navigating Post-Op Complications After Xen Microstent Implantation

65

A Superonasal Corneal Traction Suture for Ab Interno Xen Implantation

66

iStent inject W – Your go-to Device for MIGS Surgery

67

Pre-, Intra-, and Post-Operative Pearls for the MicroShunt

68

Surgical Pearls From MicroShunt Implants

69

Equal Pay for Equal Work: Closing Ophthalmology’s Gender Gap in Compensation

70

Dose & Delivery: Defining Controlled Glaucoma

71

In Advocation of Advocacy

72

Allyship: The Time is Now

73

Novel Glaucoma Medications: From Clinical Trials to Clinical Experience

74

Dose & Delivery: Evolutions in Glaucoma Management

75

Visiting the Glaucoma Clinic in the Time of COVID-19

76

Getting Started With #Ophthalmology

77

The Case for Gonioscopy

78

Newfound Insights Into Glaucoma Care

79

Moving Glaucoma Surgery Into the Clinic

80

A New Era in Visual Field Testing

81

Drive-Through IOP Checks

82

Lights, Camera, Virtual!

83

Global Outreach in the Era of COVID-19

84

Home-Based Glaucoma Monitoring

85

Intracameral Injection: Revisiting the Consensus

86

A Disease of Paradoxes

87

Cannabis and Glaucoma